Fluoxetine

Basic Fluoxetine Information

• INN (International Nonproprietary Name): Metformin
• Brand Names Available In United Kingdom: Glucophage, Bolamyn, Metabet
• ATC Code: A10BA02
• Forms & Dosages: Tablet (500mg, 850mg, 1000mg); Extended‑release (500mg, 750mg, 1000mg); Oral solution (500mg/5mL); Sachet (500mg) — as recorded in product data
• Manufacturers In United Kingdom: Not specified
• Registration Status In United Kingdom: Authorized in many countries via central or national registrations; check national databases for current product licences
• OTC / Rx Classification: Prescription‑only (Rx) in nearly all jurisdictions

Critical Warnings, Restrictions And Patient Protection (Uk Focus)

Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) with important UK‑specific precautions.

Starting any antidepressant in people aged under 25 requires urgent review and close monitoring because of a short‑term increased risk of suicidal thoughts and behaviour.

NICE guidance mandates early follow‑up and regular reviews during the first few weeks of treatment.

Pregnancy decisions must balance maternal benefit versus fetal risk and involve obstetrics and psychiatry where appropriate.

Breastfeeding requires specialist advice because fluoxetine passes into breast milk.

Elderly patients need lower starting doses and monitoring for hyponatraemia and falls risk.

Hepatic impairment requires caution due to hepatic metabolism and a longer half‑life of fluoxetine and its active metabolite.

Renal impairment does not usually require routine dose adjustment but comorbidities should be monitored closely.

Acute severe illness such as sepsis or dehydration raises the risk of adverse events and warrants review.

Driving and workplace safety must be explained to all patients as part of counselling.

Fluoxetine can cause drowsiness, dizziness or impaired concentration and patients must not drive if affected.

The UK Road Traffic Act requires drivers to be fit to drive and to stop driving if performance is impaired by medication.

Persistent impairment should be discussed with the prescriber and may require informing the DVLA.

Report suspected adverse reactions to the MHRA Yellow Card scheme and explain how patients can do this.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Under‑25s starting antidepressants need early review and safety planning per NICE.

Pregnant people should have a documented shared decision involving obstetric and mental health specialists.

Breastfeeding requires specialist input because fluoxetine is excreted in breast milk.

Elderly patients should start at a lower dose and be assessed for hyponatraemia and fall risk.

Hepatic impairment prolongs fluoxetine exposure and may necessitate dose reduction or alternative treatment.

Severe acute illnesses should prompt reassessment before continuing treatment.

Interaction With Activities (Driving, Workplace Safety Under Uk Law)

Fluoxetine can impair alertness, reaction time and concentration in some patients.

Advise not to drive, operate machinery or perform safety‑critical tasks if feeling drowsy, dizzy or less alert.

Persistent cognitive or sensory impairment should be raised with the prescriber and may need DVLA notification if it affects fitness to drive.

Employers and patients should consider workplace risk assessments where safety‑critical roles are involved.

Q&A — “Can I Drive After Taking It In The Uk?”

Not if you feel drowsy, dizzy or less alert.

If side effects persist, discuss with your GP or pharmacist.

It is the legal responsibility of the driver to stop driving while impaired and to inform the DVLA only if impairment is persistent.

• Monitoring Checklist: Arrange review at 1–2 weeks, 4 weeks and 12 weeks after initiation; assess mood, suicidality, sleep, appetite and side effects; check electrolytes and medication interactions in the elderly and those with comorbidities.
• Urgent Red Flags: New or worsening suicidal thoughts, severe agitation, signs of serotonin syndrome (high temperature, agitation, tremor), severe hyponatraemia (confusion, seizures), allergic reaction — seek emergency care.
• References: Follow NICE antidepressant monitoring schedules and MHRA Yellow Card reporting guidance.

Usage Basics

What is the drug called and what forms does it come in?

INN (International Nonproprietary Name)

Metformin

Brand Names In The United Kingdom

Glucophage; Bolamyn; Metabet (as listed in the supplied product data)

Forms

Tablets and extended‑release tablets in multiple strengths; oral solution and sachets where marketed

• Legal Classification: Prescription‑only medicine (POM) in the UK — supply requires a valid NHS or private prescription.
• Where To Check: Consult the MHRA product literature, the SmPC and local formularies for current authorisations.

Dosing Guide (NHS‑Aligned)

How is fluoxetine usually started and adjusted in adults?

Typical adult starting dose is 20 mg once daily, usually taken in the morning.

Maintenance doses commonly range between 20–40 mg daily with specialist titration up to 60 mg where indicated.

Fluoxetine has a long half‑life and an active metabolite, so steady state is slower than short‑acting SSRIs.

Abrupt stopping is less likely to cause discontinuation symptoms than short‑acting SSRIs, but withdrawal effects still occur rarely.

Elderly patients often start at 10–20 mg and are monitored for hyponatraemia, falls and interactions.

Hepatic impairment may require dose reduction or avoidance if severe.

Pregnancy and breastfeeding decisions should be individualised and documented with specialist input.

CYP interactions such as with tamoxifen may necessitate alternative antidepressants.

Standard Regimens (NHS Guidelines)

• Start 20 mg once daily for most adults unless clinical reasons to alter dose.
• Reassess at 1–2 weeks for tolerability; assess efficacy at 4–6 weeks.
• Consider 6–8 weeks at an adequate dose before deciding on non‑response.

Adjustments For Comorbidities

• Elderly: Start low (10–20 mg), monitor sodium and fall risk, review interactions.
• Hepatic impairment: Reduce dose or seek specialist advice due to prolonged metabolism.
• CYP2D6 substrates: Review drug list for potential interactions (e.g., tamoxifen) and consider alternatives.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember on the same day.

Do not double the next dose to make up for a missed one.

If more than 24 hours have passed, resume the usual schedule and inform your prescriber if several doses are missed.

Interaction Chart

What foods and medicines interact with fluoxetine?

Alcohol can increase sedation and worsen depression; patients should be advised to minimise alcohol intake.

Caffeine from tea or coffee does not have a direct pharmacological interaction but may worsen anxiety in sensitive individuals.

Key drug conflicts include monoamine oxidase inhibitors (MAOIs), triptans, other SSRIs/SNRIs, linezolid and certain antibiotics.

Antiplatelet drugs and anticoagulants plus NSAIDs increase bleeding risk when combined with SSRIs.

Fluoxetine is a CYP2D6 inhibitor and can reduce the effectiveness of prodrugs like tamoxifen.

Lithium and other serotonergic agents raise the risk of serotonin syndrome and need close monitoring.

St John’s Wort is an over‑the‑counter herbal that can precipitate serotonin syndrome and should be avoided.

Food And Drinks (Alcohol, Tea/Coffee, Diet Habits)

• Advise minimal alcohol while starting treatment and during periods of worsening mood.
• Caffeine may exacerbate anxiety or insomnia in some patients; consider moderation.
• Maintain a balanced diet and monitor weight changes over time.

Common Drug Conflicts (MhRA Yellow Card Data)

Use a clinician reference table listing interacting agent, interaction type and recommended action for rapid review.

Examples include MAOIs (contraindicated), triptans (monitor for serotonin syndrome), anticoagulants/antiplatelets (monitor bleeding), tamoxifen (consider alternative), lithium (monitor levels and toxicity signs), benzodiazepines (potentiation of sedation).

Pharmacists should check OTC and herbal remedies during every consultation.

Encourage patients and clinicians to report suspected adverse reactions to the MHRA Yellow Card scheme.

User Reports, Trends And Public Perception

What do patients say online and how should clinicians respond?

• Top Patient‑Reported Issues: Early gastrointestinal upset such as nausea; initial activation or anxiety; delayed improvement in mood; sexual dysfunction; weight changes; insomnia.
• Common Sources: NHS Choices, Patient.info, Mumsnet and other forums where pregnancy and breastfeeding risks are frequently discussed.
• Interpretation: Use patient narratives to set expectations on onset, side effects and likely timeline for benefit.

Clinicians should flag any forum reports of suicidal thoughts or severe adverse events and advise immediate clinical contact.

For SEO purposes, include patient language such as “fluoxetine side effects UK” and “Prozac UK experiences” when creating content aimed at patients.

Access And Purchase Options (Uk)

How do patients in the UK get fluoxetine?

Fluoxetine is prescription‑only and should be obtained via a GP prescription, NHS electronic prescribing or a private prescriber.

Major high‑street pharmacies including Boots, LloydsPharmacy and Superdrug dispense NHS and private prescriptions and provide pharmacist counselling.

Online pharmacies registered with the General Pharmaceutical Council (GPhC) can supply fluoxetine against a valid prescription.

Be cautious of unregulated importers and advise patients to check MHRA and GPhC credentials.

In England patients pay NHS prescription charges unless exempt; Scotland, Wales and Northern Ireland do not routinely charge for prescriptions.

In our online pharmacy, fluoxetine is available without a prescription, with discreet delivery to United Kingdom in 5‑14 days.

Boots, LloydsPharmacy, Superdrug

• These chains offer face‑to‑face counselling and repeat dispensing services.
• Pharmacists can provide adherence support and check for interactions at dispensing.

Online Pharmacies And NHS E‑Prescriptions

• Ensure online suppliers are GPhC‑registered and require a valid prescription before supply.
• Use NHS Electronic Prescription Service (EPS) for convenient collection from local pharmacies.

Mechanism Of Action & Pharmacology

How does fluoxetine work in simple terms?

Fluoxetine is an SSRI that increases synaptic serotonin by inhibiting the serotonin transporter (SERT).

The increased serotonin signal helps reduce low mood and anxiety over weeks through downstream neuroadaptive changes.

Fluoxetine is well absorbed orally and undergoes extensive hepatic metabolism.

It is a substrate and inhibitor of CYP2D6 and has a long half‑life of around 1–3 days, with an active metabolite norfluoxetine that persists for longer.

This pharmacokinetic profile supports once‑daily dosing and explains the slower onset and slower discontinuation effects compared with short‑acting SSRIs.

Simplified Explanation

Think of fluoxetine as amplifying serotonin signals in the brain to stabilise mood over weeks.

Patients often need reassurance that benefits take time and early side effects may settle.

Clinical Terms

SERT

Serotonin transporter inhibited by fluoxetine, increasing serotonin availability.

Half‑Life

Time taken for drug levels to fall by half; fluoxetine has a long half‑life with a persistent metabolite.

Metabolite

Norfluoxetine is active and prolongs overall effect.

Serotonin Syndrome

A potentially serious reaction with other serotonergic drugs (agitation, hyperreflexia, autonomic instability).

Indications & Off‑Label Uses

What is fluoxetine licensed for and where is it used off‑label?

• Licensed Indications: Major depressive disorder, obsessive‑compulsive disorder (OCD), bulimia nervosa and panic disorder depending on product licence.
• Off‑Label Uses: Chronic pain with comorbid depression, certain eating disorder permutations and adjunctive therapy in treatment‑resistant depression when supported by evidence and documented consent.

When prescribing off‑label, document rationale, discuss risks and benefits and obtain patient agreement.

For menstrual‑related mood disorders or PMDD, alternatives such as sertraline are often preferred.

MHRA‑Approved Uses

• Refer to the SmPC for each licensed product and indication.

Off‑Label Practices In NHS And Private Care

• Off‑label prescriptions should follow evidence, local formulary guidance and be recorded in the clinical record.

Key Clinical Findings (Major Uk/Eu Studies 2022–2025)

What recent evidence affects clinical practice?

• Efficacy: Meta‑analyses and NICE reviews through 2025 show SSRIs have modest to moderate benefit for moderate to severe depression and clear benefit in OCD and bulimia.
• Comparative Findings: Network meta‑analyses indicate similar overall effectiveness across SSRIs, with differing tolerability; fluoxetine often described as relatively activating with a long half‑life.
• Real‑World Data: NHS primary care cohorts report adherence challenges related to sexual dysfunction and initial activation symptoms.
• Safety: MHRA Yellow Card reports remain consistent with known adverse effects — GI upset, insomnia, sexual dysfunction, rare hyponatraemia and very rare serious events.

Clinical implication: Combine pharmacotherapy with psychological therapies such as CBT for better outcomes in resistant cases and discuss tolerability up front.

Alternatives Matrix

What are common NHS alternatives and how do they compare?

Pros And Cons Checklist

• Consider comorbid anxiety and insomnia when choosing an alternative.
• Review pregnancy history and prior antidepressant response.
• Check polypharmacy and significant CYP interactions.
• Discuss sexual side‑effects and patient preferences for dosing time.
• Document shared decision‑making and consider specialist referral for prior SSRI failure.

Common Patient Questions (3–4 FAQs From Uk Consultations)

• How Long Until I Feel Better?

  Early changes can appear in 1–2 weeks but meaningful improvement usually takes 4–6 weeks.

  Arrange review at 1–2 weeks for tolerability and at 4–6 weeks for response assessment.

• Will It Make Me Gain Weight?

  Weight change varies; some patients gain and others lose weight.

  Offer lifestyle support and monitor weight during reviews.

• Can I Drink Alcohol?

  Best to avoid or limit alcohol while taking fluoxetine because it can worsen mood and side effects.

• What About Sexual Side Effects?

  Sexual dysfunction is common and should be discussed; consider dose strategies or alternative agents if troublesome.

Clinician Action: Safety‑net for suicidal ideation, schedule follow‑ups at 1–2 and 4–6 weeks, and use Yellow Card reporting for unexpected severe effects.

Nhs Cost & Access Comparison (Table Guidance)

• Regional Differences: England uses a prescription charge system with exemptions; Scotland, Wales and Northern Ireland generally provide free prescriptions.
• Tips: Use NHS prescriptions when eligible and register with a GPhC online pharmacy for convenience; beware of unregulated suppliers.

Registration & Regulation

How is fluoxetine regulated and what should prescribers check?

Fluoxetine products are licensed and regulated by the MHRA in the UK and each brand licence lists specific indications and dosages.

Prescribers must consult the Summary of Product Characteristics (SmPC) and the Patient Information Leaflet (PIL) for licensed claims.

Pharmacovigilance relies on MHRA Yellow Card reporting for suspected adverse reactions.

NHS prescribing follows NICE guidelines, local formulary choices and shared‑care agreements where applicable.

Electronic prescribing (EPS) and repeat dispensing should be used in line with local governance and safety checks.

• Regulatory Checklist Before Prescribing: Confirm SmPC, check local formulary, review patient drug history for interactions, document indication and consent for off‑label use.

SmPC

Summary of Product Characteristics — details licensed uses and safety information.

PIL

Patient Information Leaflet supplied with the medicine.

Yellow Card

MHRA adverse reaction reporting scheme.

EPS

Electronic Prescription Service used by the NHS for prescriptions and collection.

Storage & Handling (Uk Household Climate)

How should fluoxetine be stored at home?

Store tablets at room temperature away from direct sunlight and moisture.

Avoid storing medicines in bathrooms or near the sink where steam can be present.

Typical room temperature guidance is 15–25°C unless the manufacturer specifies otherwise.

Keep medicines out of reach of children and pets and in original packaging where possible.

Oral solutions should follow the manufacturer’s storage and expiry instructions after opening.

Dispose of unused or expired medicines via pharmacy return schemes — do not flush them down the toilet.

• Travel Tips: Keep medication in original packaging with a prescription or GP letter for airport security and avoid leaving medicines in hot cars for prolonged periods.
• Pharmacy Handling: Maintain secure, labelled storage and counsel patients on correct handling at dispensing.

Guidelines For Proper Use (Practice & Pharmacist Counselling)

What should pharmacists cover when counselling on fluoxetine?

Begin with safety screening for allergies, pregnancy status and other medicines including OTC and herbal remedies.

Ask about driving, work duties and any history of bipolar disorder or suicidal ideation.

Explain the treatment timeline and common side effects and provide written PIL information.

Give clear instructions on what to do if suicidal thoughts emerge and how to seek urgent help.

Offer a follow‑up call or consultation within 1–2 weeks to check tolerance and adherence.

Document counselling in the patient record and liaise with the GP for dose changes or pregnancy planning.

Signpost NHS Talking Therapies and other self‑management resources for combined treatment approaches.

UK Pharmacist Counselling Style

• Use plain language, set realistic expectations and agree a follow‑up plan.
• Use motivational adherence techniques and provide a clear contact point for concerns.

NHS Patient Safety Advice

• Schedule review appointments at 1–2 weeks and 4–6 weeks after starting treatment.
• Ensure safety plan and emergency contacts are discussed and documented.

Delivery Across United Kingdom